Top compounds associated with response to ASPDH


Feature Type Standardized
Nominal ANOVA
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.22 2e-10
mRNA TKI258 CCLE pan-cancer AAC -0.24 2e-07
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA PX-12 CTRPv2 pan-cancer AAC 0.13 7e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 8e-06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
Download CSV